Nureca Ltd 22 Oct 2026 12:00 AM
Nureca Ltd consolidated sales up 45.09% on year in Q3FY2026, net profit surged by 31.92%,
Nureca Ltd share price ticked higher by 4.69% to Rs 332.8 after the company`s net profit soared by 31.92% to Rs 4.05 crore, while revenue from operations increased sharply by 45.09% to Rs 58.53 crore in Q3FY26 over Q2FY26. The market capitalization of Medical Equipment & Supplies industry group stocks on BSE stood at Rs 24205.38 crore, declining 6.23%. It has slipped by 7.35% over last one week and surged by 51.56% in last one month while the market capitalization of Nureca Ltd has improved by 2.75% and 10.66% in the same period respectively. Profit before tax (PBT) of Nureca Ltd stood at Rs 5.52 crore in Q3 FY26, jumping 20.00% year-on-year, and surging by 24.60% quarter-on-quarter. EBITDA came in at Rs 4 crore, expanding by 304.17% YoY and rallying 142.50% sequentially. Total expenses jumped by 44.15% to Rs 54.1 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 6.14 crore, soaring by 23.79% YoY, while employee benefits expense was at Rs 4.11 crore, falling 7.22% YoY. For the TTM ended FY26, revenue from operations surged 34.01% to Rs 146.96 crore, while net profit jumped 144.71% to Rs 2.08 crore, compared to previous TTM. EBITDA saw a sharp decline of 2130% to Rs 7.92 crore, and PBT witnessed a strong rise of 271.64% to Rs 4.98 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 3.3 crore in FY26, as against Rs 19.08 crore in FY25. Nureca Ltd gained 4.33% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 12.69% during the same period.
Nureca Ltd 21 Oct 2026 12:00 AM
Nureca Ltd consolidated sales up 45.09% on year in Q3FY2026, net profit surged by 31.92%,
Nureca Ltd share price declined by 2.93% to Rs 317.9. The Company`s net profit jumped 31.92% to Rs 4.05 crore, while revenue from operations increased sharply by 45.09% to Rs 58.53 crore in Q3FY26 over Q2FY26. The market capitalization of Medical Equipment & Supplies industry group stocks on BSE stood at Rs 23909.73 crore, declining 6.23%. It has softened by 2.18% over last one week and jumped by 64.34% in last one month while the market capitalization of Nureca Ltd has eased by 2.45% and 7.16% in the same period respectively. Profit before tax (PBT) of Nureca Ltd stood at Rs 5.52 crore in Q3 FY26, rallying 20.00% year-on-year, and expanding by 24.60% quarter-on-quarter. EBITDA came in at Rs 4 crore, jumping 304.17% YoY and surging by 142.50% sequentially. Total expenses witnessed a sharp rise of 44.15% to Rs 54.1 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 6.14 crore, witnessing a sharp rise of 23.79% YoY, while employee benefits expense was at Rs 4.11 crore, falling 7.22% YoY. For the TTM ended FY26, revenue from operations surged 34.01% to Rs 146.96 crore, while net profit soared by 144.71% to Rs 2.08 crore, compared to previous TTM. EBITDA tumbled by 2130% to Rs 7.92 crore, and PBT soared 271.64% to Rs 4.98 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 3.3 crore in FY26, as against Rs 19.08 crore in FY25. Nureca Ltd fell 5.57% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 12.46% during the same period.
Nureca Ltd 15 Oct 2026 12:00 AM
Nureca Limited files regulatory compliance certificate with Indian stock exchanges,
Nureca Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by its Registrar and Share Transfer Agent, Alankit Assignments Limited.
Nureca Ltd 14 Oct 2026 12:00 AM
Nureca Limited’s board will convene October 21 to review quarterly and half-year financials,
Nureca Limited will hold a board meeting on Wednesday, October 21, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, as announced to the BSE Limited and National Stock Exchange of India Limited.
Nureca Ltd 29 Sep 2026 12:00 AM
Nureca Limited closes trading window for insiders ahead of Q2/H1 2026 results,
Nureca Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company`s equity shares will be closed from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the second quarter and half-year ending September 30, 2026, prohibiting trading for designated persons and their immediate relatives.
Subscribe for our
newsletter
Open Account Now